Quantum BioPharma is trading 7.45% up at $3.68 in pre-market on October 2, with no confirmed company-specific catalyst.
- Shares rebounded from the October 1 close of $3.42 after consecutive daily declines.
- Positive U.S. market sentiment, with major indices up more than 0.5%, may support the move; negative biotech sector context does not explain the gain.
- No pre-market volume was provided. A search result about final study reports refers to October 2, 2025, not 2026; confidence is low because the catalyst remains unconfirmed.